Global Durvalumab Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Durvalumab Market Overview

1.1 Durvalumab Definition

1.2 Global Durvalumab Market Size Status and Outlook (2019-2032)

1.3 Global Durvalumab Market Size Comparison by Region (2019-2032)

1.4 Global Durvalumab Market Size Comparison by Type (2019-2032)

1.5 Global Durvalumab Market Size Comparison by Application (2019-2032)

1.6 Global Durvalumab Market Size Comparison by Sales Channel (2019-2032)

1.7 Durvalumab Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Durvalumab Market Snapshot

2.2 Global Durvalumab Market Volume & Revenue (2019-2025)

2.3 Global Durvalumab Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Durvalumab Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Durvalumab Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Durvalumab Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Durvalumab Market Segment Analysis by Player

3.1 Global Durvalumab Sales and Market Share by Player (2023-2025)

3.2 Global Durvalumab Revenue and Market Share by Player (2023-2025)

3.3 Global Durvalumab Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Durvalumab Market Segment Analysis by Type

4.1 Global Durvalumab Market by Type

4.1.1 2.4mL Injection

4.1.2 10mL Injection

4.2 Global Durvalumab Sales and Market Share by Type (2019-2025)

4.3 Global Durvalumab Revenue and Market Share by Type (2019-2025)

4.4 Global Durvalumab Average Price by Type (2019-2025)

4.5 Leading Players of Durvalumab by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Durvalumab Market Segment Analysis by Application

5.1 Global Durvalumab Market by Application

5.1.1 Locally Advanced Urothelial Carcinoma

5.1.2 Metastatic Urothelial Carcinoma

5.1.3 Others

5.2 Global Durvalumab Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Durvalumab by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Durvalumab Market Segment Analysis by Sales Channel

6.1 Global Durvalumab Market by Sales Channel

6.1.1 Global Durvalumab Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Durvalumab Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Durvalumab Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Durvalumab by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Durvalumab Market Segment Analysis by Region

7.1 Global Durvalumab Market Size and CAGR by Region (2019-2032)

7.2 Global Durvalumab Sales and Market Share by Region (2019-2025)

7.3 Global Durvalumab Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Durvalumab Market Share by Type

7.4.3 North America Durvalumab Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Durvalumab Market Share by Type

7.5.3 Europe Durvalumab Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Durvalumab Market Share by Type

7.6.3 Asia-Pacific Durvalumab Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Durvalumab Market Share by Type

7.7.3 South America Durvalumab Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Durvalumab Market Share by Type

7.8.3 Middle East & Africa Durvalumab Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Durvalumab Players

8.1 Medimmune (AstraZeneca)

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Others

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Durvalumab

9.1 Industrial Chain of Durvalumab

9.2 Upstream of Durvalumab

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Durvalumab

9.3.1 Leading Distributors/Dealers of Durvalumab

9.3.2 Leading Consumers of Durvalumab

Chapter 10. Global Durvalumab Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Durvalumab Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Durvalumab Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Durvalumab (2026-2032)

11.1 Global Durvalumab Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Durvalumab Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Durvalumab Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Durvalumab Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Durvalumab Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Durvalumab Import-Export (2019-2025)

12.2 Europe Durvalumab Import-Export (2019-2025)

12.3 Asia Pacific Durvalumab Import-Export (2019-2025)

12.4 South America Durvalumab Import-Export (2019-2025)

12.5 Middle East & Africa Durvalumab Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Durvalumab Demand-Supply (2019-2025)

13.2 Europe Durvalumab Demand-Supply (2019-2025)

13.3 Asia Pacific Durvalumab Demand-Supply (2019-2025)

13.4 South America Durvalumab Demand-Supply (2019-2025)

13.5 Middle East & Africa Durvalumab Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources